The Job

We are looking for a highly skilled UX/UI Research Manager who will play an integral role on a growing team focused on patient-centered research. This critical role will ensure we keep the “patient at the table” at all stages in the product development lifecycle as we design digital therapeutics in the form of mobile games as well as symptom and behavior-tracking apps.

What It Entails

• • Empathic researcher with a facility for building rapport and a passion for understanding users’ needs
  • Independent and proactive problem solver  
  • Strategic thinker with strong planning, prioritization, and time-management skills
  • Team player who collaborates effectively with participants, peers, product managers, designers, and team leads
  • Skilled communicator who is adept at moderating, synthesizing, writing, presenting, and influencing

What You Need

• • 5+ years experience in UX/UI research
  • 5+ years experience testing mobile games
  • 5+ years experience testing mobile and web applications
  • Demonstrated mastery of user-centered research methods; practical experience with a wide variety of qualitative and quantitative research methods
  • Bachelor’s or Master’s degree in behavioral science (e.g., human-centered design and research, psychology, sociology, anthropology, cognitive science)

It’s Great If You Also Have

• Experience building an internal UX/UI research lab
• Experience working with children and/or vulnerable populations

Akili – The Company

Akili Interactive (www.akiliinteractive.com) is pioneering the field of digital therapeutics, combining scientific and clinical rigor with the ingenuity of the tech industry to develop novel digital medicines designed to treat cognitive dysfunction and brain-related conditions.

Akili’s flagship product, AKL-T01 in pediatric ADHD, is now under review by FDA for clearance following Akili’s recent filing. Akili previously announced positive top-line results of a multi-center, randomized, double-blind, controlled pivotal study evaluating the safety and efficacy of AKL-T01. If cleared by FDA, AKL-T01 would be the first prescription video game to treat a medical condition and the first prescription digital medicine for children with ADHD. The product is based on technology developed at UCSF that was featured as the cover article in Nature under the headline “Game Changer.”

Akili was founded by leading neuroscientists and top-tier game design veterans to create gaming experiences that are designed to directly treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and psychiatry. Akili has partnerships with top pharmaceutical companies, and has received recent recognition in major media outlets including the Wall Street Journal, CNBC, Fast Company, and The Verge.

Please click here to apply.